Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
letter
. 1998 Nov;106(11):A526–A527. doi: 10.1289/ehp.106-1533489

Lifetime risk from polyurethane covered breast implants.

K Kulig
PMCID: PMC1533489  PMID: 9882175

Full text

PDF
A526

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley F. L. Further studies on the natural-Y breast prosthesis. Plast Reconstr Surg. 1972 Apr;49(4):414–419. doi: 10.1097/00006534-197204000-00009. [DOI] [PubMed] [Google Scholar]
  2. Capozzi A., Pennisi V. R. Clinical experience with polyurethane-covered gel-filled mammary prostheses. Plast Reconstr Surg. 1981 Oct;68(4):512–520. doi: 10.1097/00006534-198110000-00006. [DOI] [PubMed] [Google Scholar]
  3. Chan S. C., Birdsell D. C., Gradeen C. Y. Detection of toluenediamines in the urine of a patient with polyurethane-covered breast implants. Clin Chem. 1991 May;37(5):756–758. [PubMed] [Google Scholar]
  4. Cohney B. C., Cohney T. B., Hearne V. A. Augmentation mammaplasty--a further review of 20 years using the polyurethane-covered prosthesis. J Long Term Eff Med Implants. 1992;1(3):269–279. [PubMed] [Google Scholar]
  5. DUNAIF C. B., STUBENBORD W. T., CONWAY H. OBSERVATIONS ON SUBCUTANEOUSLY IMPLANTED POLYETHERURETHANE SPONGE IN MICE. Surg Gynecol Obstet. 1963 Oct;117:454–458. [PubMed] [Google Scholar]
  6. Delclos K. B., Blaydes B., Heflich R. H., Smith B. A. Assessment of DNA adducts and the frequency of 6-thioguanine resistant T-lymphocytes in F344 rats fed 2,4-toluenediamine or implanted with a toluenediisocyanate-containing polyester polyurethane foam. Mutat Res. 1996 Apr 6;367(4):210–218. [PubMed] [Google Scholar]
  7. Green A., Willett W. C., Colditz G. A., Stampfer M. J., Bain C., Rosner B., Hennekens C. H., Speizer F. E. Use of permanent hair dyes and risk of breast cancer. J Natl Cancer Inst. 1987 Aug;79(2):253–257. [PubMed] [Google Scholar]
  8. Grodstein F., Hennekens C. H., Colditz G. A., Hunter D. J., Stampfer M. J. A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst. 1994 Oct 5;86(19):1466–1470. doi: 10.1093/jnci/86.19.1466. [DOI] [PubMed] [Google Scholar]
  9. HARRIS H. I. Research in plastic implants. Their use in augmentation for amastia or hypomastia. J Int Coll Surg. 1961 May;35:630–643. [PubMed] [Google Scholar]
  10. HOLLENBERG C., MACOOMB R. K., TROTT J. R., ZINGG W. An investigation of polyurethane foam in experimental animals. Can J Surg. 1963 Jul;6:371–382. [PubMed] [Google Scholar]
  11. Hagmar L., Welinder H., Mikoczy Z. Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry. Br J Ind Med. 1993 Jun;50(6):537–543. doi: 10.1136/oem.50.6.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hester T. R., Jr, Ford N. F., Gale P. J., Hammett J. L., Raymond R., Turnbull D., Frankos V. H., Cohen M. B. Measurement of 2,4-toluenediamine in urine and serum samples from women with Même or Replicon breast implants. Plast Reconstr Surg. 1997 Oct;100(5):1291–1298. doi: 10.1097/00006534-199710000-00035. [DOI] [PubMed] [Google Scholar]
  13. Koenig K. L., Pasternack B. S., Shore R. E., Strax P. Hair dye use and breast cancer: a case-control study among screening participants. Am J Epidemiol. 1991 May 15;133(10):985–995. doi: 10.1093/oxfordjournals.aje.a115818. [DOI] [PubMed] [Google Scholar]
  14. Luu H. M., Hutter J. C., Bushar H. F. A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants. Environ Health Perspect. 1998 Jul;106(7):393–400. doi: 10.1289/ehp.98106393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ramsey J. C., Andersen M. E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol. 1984 Mar 30;73(1):159–175. doi: 10.1016/0041-008x(84)90064-4. [DOI] [PubMed] [Google Scholar]
  16. Schnorr T. M., Steenland K., Egeland G. M., Boeniger M., Egilman D. Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry. Occup Environ Med. 1996 Oct;53(10):703–707. doi: 10.1136/oem.53.10.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sorahan T., Pope D. Mortality and cancer morbidity of production workers in the United Kingdom flexible polyurethane foam industry. Br J Ind Med. 1993 Jun;50(6):528–536. doi: 10.1136/oem.50.6.528. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES